Organization Profile

You just read:

Lundbeck Canada Inc. Announces Health Canada Approval of Trintellix™ (vortioxetine hydrobromide) for Treatment of Adults with Major Depressive Disorder

News provided by

Lundbeck Canada Inc.

Oct 28, 2014, 05:59 ET